Adverse reactions to the non-drug constituents of nebuliser solutions.
作者信息
Beasley R, Rafferty P, Holgate S T
机构信息
Immunopharmacology Group, Southampton General Hospital.
出版信息
Br J Clin Pharmacol. 1988 Mar;25(3):283-7. doi: 10.1111/j.1365-2125.1988.tb03305.x.
Abstract
摘要
相似文献
1
Adverse reactions to the non-drug constituents of nebuliser solutions.雾化器溶液中非药物成分的不良反应。
Br J Clin Pharmacol. 1988 Mar;25(3):283-7. doi: 10.1111/j.1365-2125.1988.tb03305.x.
2
A non-bronchoconstrictor, bacteriostatic preservative for nebuliser solutions.一种用于雾化溶液的非支气管收缩性抑菌防腐剂。
Br J Clin Pharmacol. 1991 Feb;31(2):204-6. doi: 10.1111/j.1365-2125.1991.tb05517.x.
3
Microbial contamination of nebulization solution and its measures.雾化溶液的微生物污染及其防治措施。
Biol Pharm Bull. 2006 Mar;29(3):503-7. doi: 10.1248/bpb.29.503.
4
Bronchoconstrictor properties of preservatives in ipratropium bromide (Atrovent) nebuliser solution.异丙托溴铵（爱全乐）雾化溶液中防腐剂的支气管收缩特性。
Br Med J (Clin Res Ed). 1987 May 9;294(6581):1197-8. doi: 10.1136/bmj.294.6581.1197-a.
5
Effect of preservative on the efficacy of terbutaline nebuliser solution in atopic asthma.防腐剂对特布他林雾化液治疗变应性哮喘疗效的影响。
Thorax. 1993 May;48(5):566-8. doi: 10.1136/thx.48.5.566.
6
Intrathecal injections--a review of pharmaceutical factors.鞘内注射——药物因素综述
Bull Parenter Drug Assoc. 1977 Sep-Oct;31(5):237-47.
7
[Preservatives in nebulizer solutions: risks without benefit].[雾化器溶液中的防腐剂：有风险而无益处]
J Pharm Belg. 1999 Mar-Apr;54(2):38-43.
8
Comparison of the efficacy of preservative free ipratropium bromide and Atrovent nebuliser solution.不含防腐剂的异丙托溴铵与爱全乐雾化液疗效比较。
Thorax. 1988 Jun;43(6):446-50. doi: 10.1136/thx.43.6.446.
9
"Inactive" ingredients in pharmaceutical products: update (subject review). American Academy of Pediatrics Committee on Drugs.药品中的“非活性”成分：更新（专题综述）。美国儿科学会药物委员会
Pediatrics. 1997 Feb;99(2):268-78. doi: 10.1542/peds.99.2.268.
10
Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis.用于治疗角膜胱氨酸病的盐酸半胱胺粘性溶液的制剂及体外评价
Eur J Pharm Biopharm. 2008 Sep;70(1):260-9. doi: 10.1016/j.ejpb.2008.04.010. Epub 2008 Apr 24.
引用本文的文献
1
Nebulizers effectiveness on pulmonary delivery of alpha-1 antitrypsin.雾化器对α-1 抗胰蛋白酶肺部给药的效果。
Drug Deliv Transl Res. 2023 Oct;13(10):2653-2663. doi: 10.1007/s13346-023-01346-3. Epub 2023 Apr 25.
2
Nebulised Isotonic Hydroxychloroquine Aerosols for Potential Treatment of COVID-19.雾化吸入等渗羟氯喹气雾剂用于COVID-19的潜在治疗
Pharmaceutics. 2021 Aug 14;13(8):1260. doi: 10.3390/pharmaceutics13081260.
3
Inhaled antibodies: formulations require specific development to overcome instability due to nebulization.吸入型抗体：由于雾化作用导致的不稳定性，制剂需要专门开发。
Drug Deliv Transl Res. 2021 Aug;11(4):1625-1633. doi: 10.1007/s13346-021-00967-w. Epub 2021 Mar 25.
4
In vitro characterization of the I-neb Adaptive Aerosol Delivery (AAD) system.I-neb 自适应雾化输送（AAD）系统的体外特性分析。
J Aerosol Med Pulm Drug Deliv. 2010 Apr;23 Suppl 1(Suppl 1):S11-20. doi: 10.1089/jamp.2009.0792.
5
Physicochemical compatibility of fluticasone-17- propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions.丙酸氟替卡松雾化混悬液与异丙托溴铵及沙丁胺醇雾化溶液的物理化学相容性
Int J Chron Obstruct Pulmon Dis. 2007;2(4):599-607.
6
Assessment of different methods of inhalation from salbutamol metered dose inhalers by urinary drug excretion and methacholine challenge.通过尿药排泄和乙酰甲胆碱激发试验评估沙丁胺醇定量气雾剂不同吸入方法
Br J Clin Pharmacol. 2005 Dec;60(6):605-10. doi: 10.1111/j.1365-2125.2005.02499.x.
7
In vitro assessment of drug delivery through an endotracheal tube using a dry powder inhaler delivery system.使用干粉吸入器给药系统通过气管导管进行药物递送的体外评估。
Thorax. 1996 Jan;51(1):75-7. doi: 10.1136/thx.51.1.75.
8
Effect of preservative on the efficacy of terbutaline nebuliser solution in atopic asthma.防腐剂对特布他林雾化液治疗变应性哮喘疗效的影响。
Thorax. 1993 May;48(5):566-8. doi: 10.1136/thx.48.5.566.
9
Survey of colourings and preservatives in drugs.药品中色素和防腐剂的调查。
BMJ. 1989 Sep 9;299(6700):649-51. doi: 10.1136/bmj.299.6700.649.
10
A non-bronchoconstrictor, bacteriostatic preservative for nebuliser solutions.一种用于雾化溶液的非支气管收缩性抑菌防腐剂。
Br J Clin Pharmacol. 1991 Feb;31(2):204-6. doi: 10.1111/j.1365-2125.1991.tb05517.x.
本文引用的文献
1
THE POTENTIAL ROLE OF INHALATION THERAPY EQUIPMENT IN NOSOCOMIAL PULMONARY INFECTION.吸入治疗设备在医院获得性肺部感染中的潜在作用
J Clin Invest. 1965 May;44(5):831-9. doi: 10.1172/JCI105195.
2
Lower threshold and greater bronchomotor responsiveness of asthmatic subjects to sulfur dioxide.哮喘患者对二氧化硫的阈值较低且支气管运动反应性较高。
Am Rev Respir Dis. 1980 Dec;122(6):873-8. doi: 10.1164/arrd.1980.122.6.873.
3
Exercise increases sulfur dioxide-induced bronchoconstriction in asthmatic subjects.运动可加剧哮喘患者二氧化硫诱发的支气管收缩。
Am Rev Respir Dis. 1981 May;123(5):486-91. doi: 10.1164/arrd.1981.123.5.486.
4
Anaphylaxis to a component of isoetharine (sodium bisulfite).
JAMA. 1982 Oct 22;248(16):2030-1.
5
Effect of pH on bronchial response to inhaled histamine.pH值对支气管对吸入组胺反应的影响。
Thorax. 1982 Feb;37(2):133-6. doi: 10.1136/thx.37.2.133.
6
Bacterial contamination of aerosol solutions used to treat cystic fibrosis.
Am J Hosp Pharm. 1982 Feb;39(2):308-9.
7
Airway response to water inhalation: a new test for "bronchial reactivity".
N Engl J Med. 1981 Sep 17;305(12):702. doi: 10.1056/NEJM198109173051221.
8
The effects of inhaled sulfuric acid on pulmonary function in adolescent asthmatics.吸入硫酸对青少年哮喘患者肺功能的影响。
Am Rev Respir Dis. 1983 Aug;128(2):221-5. doi: 10.1164/arrd.1983.128.2.221.
9
Evaluation of ultrasonically nebulised solutions for provocation testing in patients with asthma.超声雾化溶液用于哮喘患者激发试验的评估。
Thorax. 1983 Apr;38(4):284-91. doi: 10.1136/thx.38.4.284.
10
Zotero 插件